Literature DB >> 14689202

[Highly active antiretroviral therapy of HIV patients. ART Cohort Collaboration].

A Schmid1, H H Hirsch.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14689202     DOI： 10.1007/s00108-003-1097-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN： 0020-9554            Impact factor:   0.743


× No keyword cloud information.
  5 in total

Review 1.  Hit HIV-1 hard, but only when necessary.

Authors:  M Harrington; C C Carpenter
Journal:  Lancet       Date:  2000-06-17       Impact factor: 79.321

2.  Time to hit HIV, early and hard.

Authors:  D D Ho
Journal:  N Engl J Med       Date:  1995-08-17       Impact factor: 91.245

Review 3.  Lipodystrophy syndrome by HAART in HIV-infected patients: manifestation, mechanisms and management.

Authors:  H H Hirsch; M Battegay
Journal:  Infection       Date:  2002-10       Impact factor: 3.553

4.  Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.

Authors:  Mark Dybul; Anthony S Fauci; John G Bartlett; Jonathan E Kaplan; Alice K Pau
Journal:  MMWR Recomm Rep       Date:  2002-05-17

5.  Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Authors:  Matthias Egger; Margaret May; Geneviève Chêne; Andrew N Phillips; Bruno Ledergerber; François Dabis; Dominique Costagliola; Antonella D'Arminio Monforte; Frank de Wolf; Peter Reiss; Jens D Lundgren; Amy C Justice; Schlomo Staszewski; Catherine Leport; Robert S Hogg; Caroline A Sabin; M John Gill; Bernd Salzberger; Jonathan A C Sterne
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321
  5 in total
  1 in total

1.  Reliability of CD4 quantitation in human immunodeficiency virus-positive children: implications for definition of immunologic response to highly active antiretroviral therapy.

Authors:  Vincent J Carey; Savita Pahwa; Adriana Weinberg
Journal:  Clin Diagn Lab Immunol       Date:  2005-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.